Geneva Capital Management’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4M | Buy |
901,764
+49,637
| +6% | +$1.07M | 0.33% | 77 |
|
|
2025
Q1 | $19.5M | Sell |
852,127
-614
| -0.1% | -$14K | 0.36% | 75 |
|
|
2024
Q4 | $22.1M | Sell |
852,741
-12,525
| -1% | -$325K | 0.38% | 74 |
|
|
2024
Q3 | $21.7M | Buy |
865,266
+965
| +0.1% | +$24.2K | 0.36% | 83 |
|
|
2024
Q2 | $18.5M | Sell |
864,301
-15,914
| -2% | -$341K | 0.34% | 81 |
|
|
2024
Q1 | $16.3M | Buy |
880,215
+5,730
| +0.7% | +$106K | 0.29% | 88 |
|
|
2023
Q4 | $14.2M | Sell |
874,485
-650,906
| -43% | -$10.6M | 0.27% | 89 |
|
|
2023
Q3 | $21.1M | Sell |
1,525,391
-36,052
| -2% | -$498K | 0.44% | 73 |
|
|
2023
Q2 | $34.5M | Buy |
1,561,443
+2,750
| +0.2% | +$60.8K | 0.68% | 54 |
|
|
2023
Q1 | $33.9M | Buy |
1,558,693
+38,640
| +3% | +$840K | 0.69% | 54 |
|
|
2022
Q4 | $27.7M | Sell |
1,520,053
-17,583
| -1% | -$320K | 0.62% | 58 |
|
|
2022
Q3 | $35M | Buy |
1,537,636
+84,435
| +6% | +$1.92M | 0.81% | 50 |
|
|
2022
Q2 | $20.1M | Sell |
1,453,201
-3,455
| -0.2% | -$47.7K | 0.46% | 84 |
|
|
2022
Q1 | $33.1M | Sell |
1,456,656
-32,348
| -2% | -$735K | 0.64% | 65 |
|
|
2021
Q4 | $55.5M | Buy |
1,489,004
+177,875
| +14% | +$6.63M | 0.89% | 44 |
|
|
2021
Q3 | $55.5M | Buy |
1,311,129
+284,432
| +28% | +$12M | 0.94% | 41 |
|
|
2021
Q2 | $45.7M | Sell |
1,026,697
-6,398
| -0.6% | -$285K | 0.74% | 60 |
|
|
2021
Q1 | $37.2M | Buy |
+1,033,095
| New | +$37.2M | 0.63% | 67 |
|